
Sign up to save your podcasts
Or
Max Jaderberg, Director of Machine learning at Isomorphic labs, shares the Isomorphic approach to drug discovery in one of their first interviews as they emerge from shadow mode.
- Bottlenecks in the drug discovery process and how AI could circumvent them
- How AI may unlock 'undraggable targets' to find treatments for incurable diseases
Max Jaderberg, Director of Machine learning at Isomorphic labs, shares the Isomorphic approach to drug discovery in one of their first interviews as they emerge from shadow mode.
- Bottlenecks in the drug discovery process and how AI could circumvent them
- How AI may unlock 'undraggable targets' to find treatments for incurable diseases
890 Listeners
490 Listeners
382 Listeners
6,834 Listeners
3,682 Listeners
5 Listeners
1,013 Listeners
3,152 Listeners
0 Listeners
976 Listeners
805 Listeners
2,217 Listeners